SCHEMBL10047322

SCHEMBL10047322

Cc1ccc(S(=O)(=O)N=Cc2cccc3ccccc23)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
ALDH1A1 P00352 4/20 0.47
LMNA P02545 4/20 0.46
GAA P10253 2/20 0.46
RRM1 P23921 1/20 0.45
MAPT P10636 2/20 0.42
HKDC1 Q2TB90 1/20 0.42
S100A4 P26447 1/20 0.42
HTT P42858 1/20 0.42
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
MAPK1 P28482 1/20 0.41
F2 P00734 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444215 1.00 POLB (0.50) POLBALDH1A1LMNAGAARRM1
SCHEMBL21649967 0.84 POLB (0.44) POLBALDH1A1LMNAGAAMAPT
SCHEMBL21649968 0.83 ALDH1A1 (0.46) POLBALDH1A1LMNAGAARRM1
SCHEMBL5746395 0.81 POLB (0.55) POLBALDH1A1LMNAGAAMAPT
SCHEMBL5746398 0.81 POLB (0.55) POLBALDH1A1LMNAGAAMAPT
SCHEMBL26973708 0.81 RRM1 (0.50) POLBALDH1A1LMNAGAARRM1
SCHEMBL31615502 0.79 RRM1 (0.67) POLBALDH1A1LMNAGAARRM1
SCHEMBL27939746 0.79 RRM1 (0.67) POLBALDH1A1LMNAGAARRM1
SCHEMBL31556700 0.79 POLB (0.52) POLBALDH1A1LMNAGAAMAPT
SCHEMBL18343544 0.79 POLB (0.52) POLBALDH1A1LMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB POLB 2318/4885ALDH1A1 1074/4885LMNA 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.